Clinical Trial Update: Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the radiotracer [123I] AV83 with SPECT to compare Alzheimer's disease patients against healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• [123I] AV83 (AV83)

Snippet

Sponsor: Molecular NeuroImaging | Conditions: Alzheimers Disease | Phase 1 | Status: COMPLETED